Efficacy of Multiple Nerve Blocks on the Recovery of Patients Undergoing Off Pump CABG Surgeries

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAin Shams University

About this trial

In cardiac surgery patients , effective pain control is crucial to support early extubation, mobilization, and cognitive recovery, yet systemic opioids carry substantial risks such as respiratory depression, delirium, and delayed rehabilitation. While regional fascial plane blocks offer a safer, opioid-sparing alternative, no single technique provides complete analgesia for the complex and multi-dermatomal pain generated by sternotomy, graft harvesting, chest wall retraction, and drain sites. Therefore, a multimodal approach combining blocks such as parasternal nerve block , rectus sheath nerve block and femoral nerve block , may cover most of areas expected to be sources of intraoperative and post-operative pain in cardiac surgery patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

o Scheduled for elective off-pump coronary artery bypass graft (OPCAB) surgery via median sternotomy

American Society of Anesthesiologists (ASA) physical status III - IV

Ability to provide informed consent

Disqualifiers

o Emergency or redo cardiac surgery

On-pump CABG or concomitant valve or aortic procedures

Known allergy to local anesthetics or study drugs

Coagulopathy or ongoing anticoagulant therapy contraindicating regional block

Trial design

Design model

Parallel

Treatments tested in this trial

  • regional nerve block with local anesthesia

    Procedure/Surgery

    Patients will receive bilateral superficial parasternal nerve block using 20 mL of 0.25% bupivacaine per side, in combination with a rectus sheath block (RSB) using 10 mL of 0.25% bupivacaine per side. and femoral nerve block at the side of harvesting using 10 mL of 0.25% bupivacaine.

  • Placebo

    Procedure/Surgery

    Patients will receive placebo (saline) injections administered in the same anatomical planes.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Group A (intervention)Active comparator 1 intervention
Group B: Group B ( control)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time to Extubation

Defined as the interval (in hours) from transferal to ICU to successful tracheal extubation

Time frame
from transferal to ICU until successful tracheal extubation assessed during post operative ICU stay up to 48 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.